FDA Issues Warning Letters Regarding Counterfeit Avastin

FDA has notified 19 US medical practices that purchased fake 400 mg/16 mL Avastin from Quality Specialty Products (QSP), a foreign supplier that the agency said may also be known as Montana Health Care Solutions.

The counterfeit version of the Roche cancer drug Avastin that has sparked FDA warning letters is a reminder of the perils posed by those manufacturing and distributing fake drugs overseas.

FDA said it notified 19 US medical practices that purchased fake 400 mg/16 mL Avastin from Quality Specialty Products (QSP), a foreign supplier that the agency said may also be known as Montana Health Care Solutions. Distributors of QSP products include Volunteer Distribution in Gainesboro, TN. In a statement, FDA said it "requested that the medical practices stop using any remaining products from these suppliers.”

The counterfeit Avastin is distinguishable from the real drug. It carries an Avastin label written in French with the Roche